You are here:Home-Webinars-From discovery to the pre-clinical antimicrobial candidate

From discovery to the pre-clinical antimicrobial candidate

Speakers:

  • Patricia Bradford, Antimicrobial Development Specialists LLC (US)
  • Alita Miller, Entasis Therapeutics (US)

Moderator: Michael Mourez, École d’Ingénieurs de PURPAN (France)

The presentations will be followed by a Q&A session.

This live webinar including interactive Q&A session will be broadcast on 25 February 2021 at 17:00-18:30 CET. Find your time zone here.

If you have questions or comments, please let us know: revive@gardp.org.

Register here!
2020-12-09T10:49:43+00:00

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. We were created to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live. We aim to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children.

CONNECT